Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Transfection of embryo fibroblasts by a human ras oncogene does not convert them into tumour cells unless the fibroblasts are established and immortalized before transfection. The embryo fibroblasts become tumorigenic if a second oncogene such as a viral or cellular myc gene or the gene for the polyoma large-T antigen is introduced together with the ras gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“ras cooperates, however, with certain other oncogenic alterations to transform primary rodent cells (Land et al. 1983; Ruley 1983), including overexpression of c-Myc, dominant negative p53, D-type cyclins, and Cdc25A and -B, and loss of p53, p16, or IRF-1”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“In that setting, dysfunctional telomeres induced a strong cellular senescence phenotype in the emerging lymphomas resulting in potent suppression of lymphomagenesis.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [93]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Self-citationRuley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citationDer, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Research works printed but not linked: 9
- Berenblum, I. & Shubik, P. Br. J. Cancer 1, 388 (1947).
- Emmelot, P. & Scherer, E. Cancer Res. 37, 1702–1708 (1977).
- Crawford, B. D., Barrett, J. C. & Ts'o, P. O. P. Molec. cell. Biol. 3, 931–945 (1983). · doi:10.1128/mcb.3.5.931
- Murray, M. J. et al. Cell (in the press).
- Aaronson, S. A. & Todaro, G. J. J. Cell Biol. 72, 141–148 (1968).
- Perucho, M., Hanahan, D. & Wigler, M. Cell 22, 309–317 (1980). · DOI · Paper page
- Beard, J. W. in Viral Oncology (ed. Klein, G.) 55–88 (Raven, New York, 1980).
- Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. & Cory, S. Proc. natn. Acad. Sci. U.S.A. (in the press).
- Gross, L. Oncogenic viruses, 931 (Pergamon, Oxford, 1970).
Cited by
Items 801–900 of 1,010
Geisen, C., & Möröy, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205919200 · Cited by 85
Differential oncogenic potential of activated RAS isoforms in melanocytes
Whitwam, T., VanBrocklin, M. W., Russo, M. E., Haak, P. T., Bilgili, D., Resau, J. H., Koo, H.-M., & Holmen, S. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210239 · Cited by 81
“It has been established that RAS and MYC can cooperate in the transformation of rodent fibroblast and mammary epithelial cells (Land et al., 1983; Sinn et al., 1987).”
BackgroundMethodInfluentialNanog transforms NIH3T3 cells and targets cell-type restricted genes
Piestun, D., Kochupurakkal, B. S., Jacob‐Hirsch, J., Zeligson, S., Koudritsky, M., Domany, E., Amariglio, N., Rechavi, G., & Givol, D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.152 · Cited by 79
“Foci assays [16] were done using NIH3T3 fibroblasts infected with viruses encoding Nanog, H-RasV12 or a control plasmid in six-well plates.”
MethodThe Human Trithorax Protein hASH2 Functions as an Oncoprotein
Lüscher‐Firzlaff, J., Gawlista, I., Vervoorts, J., Kapelle, K., Braunschweig, T. A., Walsemann, G., Rodgarkia-Schamberger, C., Schuchlautz, H., Dreschers, S., Kremmer, E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3158 · Cited by 82
“Therefore, we tested for the transforming activity of ASH2 using the rat embryo fibroblast (REF) cotransformation assay ( 37 ).”
MethodCatecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression
Zimmer, H. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050176 · Cited by 73
“ment from the mouse clone pSV cmyc-1 containing exon 2 and 3 [39], 18 S: 350-bp fragment from mouse clone N1 [40].”
BackgroundHurlin, P. J., Maher, V. M., & McCormick, J. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.187 · Cited by 73
WRANA, J. L., SODEK, J., BER, R. L., & BELLOWS, C. G. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09834.x · Cited by 73
Anti-peptide antibodies detect oncogene-related proteins in urine.
Niman, H. L., Thompson, A. M., Yu, A. L.-T., Markman, M., Willems, J. J., Herwig, K. R., Habib, N., Wood, C. B., Houghten, R. A., & Lerner, R. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.7924 · Cited by 73
Coding sequence and expression of the homeobox gene Hox 1.3
Fibi, M. R., Zink, B., Kessel, M., Colberg‐Poley, A. M., Labeit, S., Lehrach, H., & Gruß, P. (1988) · Development · doi:10.1242/dev.102.2.349 · Cited by 73
Cell Fusion Connects Oncogenesis with Tumor Evolution
Zhou, X., Merchak, K., Lee, W., Grande, J. P., Cascalho, M., & Platt, J. L. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.03.014 · Cited by 75
v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer.
Mabry, M., Nakagawa, T., Nelkin, B. D., McDowell, E. M., Gesell, M. S., Eggleston, J., Casero, R. A., & Baylin, S. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6523 · Cited by 72
Oncogenes, tumour suppressors and viruses in oral squamous carcinoma
Scully, C. M. (1993) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1993.tb01086.x · Cited by 93
The human papillomavirus E7 protein as a transforming and transactivating factor
Münger, K., & Phelps, W. C. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90025-8 · Cited by 94
Unlimited Mileage from Telomerase?
de Lange, T., & DePinho, R. A. (1999) · Science · doi:10.1126/science.283.5404.947 · Cited by 71
Sarid, J., Halazonetis, T. D., Murphy, W., & Leder, P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.170 · Cited by 72
Blake, D. R., Vaseva, A. V., Hodge, R. G., Kline, M. P., Gilbert, T. S. K., Tyagi, V., Huang, D., Whiten, G. C., Larson, J. E., Wang, X., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav7259 · Cited by 71
“This association was first demonstrated when it was shown that MYC overexpression was necessary to support RAS transformation of rodent fibroblasts (8).”
BackgroundCell hydration as the primary factor in carcinogenesis: A unifying concept
McIntyre, G. I. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.09.022 · Cited by 80
Telomeres, telomerase, and cancer: life on the edge of genomic stability
Oulton, R., & Harrington, L. A. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200001000-00013 · Cited by 78
Cross signaling, cell specificity, and physiology
Dumont, J. E., Dremier, S., Pirson, I., & Maenhaut, C. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00581.2001 · Cited by 73
Ueno, H., Perryman, M. B., Roberts, R., & Schneider, M. D. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.5.1911 · Cited by 71
“5-kbp Xbal-Hind III restriction fragment was isolated from plasmid pSVc-myc-1, containing exons 2 and 3 of murine c-myc (20).”
LaRose, A., Dyson, N. J., Sullivan, M., Harlow, E., & Bastin, M. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2308-2313.1991 · Cited by 82
“It can reduce the serum requirement of established cell lines and act in concert with other oncogenes to transform primary cells or induce tumors upon inoculation into newborn rats (2, 3, 29, 38).”
BackgroundBiochemical analysis of the ligand for the neu oncogenic receptor
Yarden, Y., & Peles, E. (1991) · Biochemistry · doi:10.1021/bi00228a027 · Cited by 71
Denny, C. T., Hollis, G. F., MAGRATH, I. T., & Kirsch, I. R. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3199 · Cited by 71
Asselin, C., & Bastin, M. (1985) · Journal of Virology · doi:10.1128/jvi.56.3.958-968.1985 · Cited by 71
“Similarly, the adenovirus ElA gene can behave as a second-step conversion gene in immortalized Chinese hamster cells (43), although it is usually considered to be an immortalizing gene (20, 36).”
BackgroundResultEpstein–Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b
Anastasiadou, E., Boccellato, F., Vincenti, S., Rosato, P. C., Bozzoni, I., Frati, L., Faggioni, A., Presutti, C., & Trivedi, P. (2009) · Oncogene · doi:10.1038/onc.2009.439 · Cited by 70
“Ras oncogene facilitates transformation by c-myc (Land et al., 1983).”
An In vitro Multistep Carcinogenesis Model for Human Cervical Cancer
Narisawa-Saito, M., Yoshimatsu, Y., Ohno, S.-I., Yugawa, T., Egawa, N., Fujita, M., Hirohashi, S., & Kiyono, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6862 · Cited by 68
Tevethia, M. J. (1984) · Virology · doi:10.1016/0042-6822(84)90234-4 · Cited by 70
Jiwa, N. M., Kanavaros, P., van der Valk, P., Walboomers, J. M. M., Horstman, A., Vos, W., Mullink, H., & Meijer, C. J. L. M. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.3.211 · Cited by 70
Santer, U. V., Gilbert, F., & Glick, M. C. (1984) · PubMed · Cited by 75
Functional Relation Between HTLV-II x and Adenovirus E1A Proteins in Transcriptional Activation
Chen, I. S. Y., Cann, A. J., Shah, N. P., & Gaynor, R. B. (1985) · Science · doi:10.1126/science.2996140 · Cited by 74
Nonsense mutation in open reading frame E2 of bovine papillomavirus DNA
DiMaio, D. (1986) · Journal of Virology · doi:10.1128/jvi.57.2.475-480.1986 · Cited by 70
“A second transformation assay was used (12) to assess the biological activity of the amber mutant.”
MethodWang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
Augmentation of Oridonin-Induced Apoptosis Observed With Reduced Autophagy
Cui, Q., Tashiro, S., Onodera, S., & Ikejima, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj06003x · Cited by 72
Aberrant signaling pathways in pancreatic cancer: A two compartment view
McCleary‐Wheeler, A. L., McWilliams, R. R., & Fernández-Zapico, M. E. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20827 · Cited by 88
“In general, MYC deregulation alone does not result in transformation, but its cooperation with other oncogenic pathways, such as RAS, is sufficient to promote tumorigenesis [108].”
BackgroundSIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress
McBurney, M. W., Clark-Knowles, K. V., Caron, A. Z., & Gray, D. A. (2013) · Genes & Cancer · doi:10.1177/1947601912474893 · Cited by 72
Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.
Suganuma, M., Kurusu, M., Okabe, S., Sueoka, N., Yoshida, M., Wakatsuki, Y., & Fujiki, H. (2001) · PubMed · Cited by 69
HER-2/neu-targeting gene therapy-a review
Hung, M., Matin, A., Zhang, Y., Xing, X., Sorgi, F. L., Huang, L., & Yu, D. (1995) · Gene · doi:10.1016/0378-1119(94)00459-6 · Cited by 69
Veyrune, J., Campbell, G. P., Wiseman, J., Blanchard, J., & Hesketh, J. E. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1185 · Cited by 69
Cell death of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis
Simm, A., Bertsch, G., Frank, H., Zimmermann, U., & Hoppe, J. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.7.819 · Cited by 69
Donor cell leukemia developing six years after marrow grafting for acute leukemia
Witherspoon, R., Schubach, W. H., Neiman, P. E., Martin, P., & Thomas, E. D. (1985) · Blood · doi:10.1182/blood.v65.5.1172.1172 · Cited by 69
Wei, W., Jobling, W. A., Chen, W., Hahn, W. C., & Sedivy, J. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2859-2870.2003 · Cited by 68
“For example, normal mouse embryo fibroblasts are easily transformed by the combined expression of an activated oncogene, such as HaRas (referred to hereafter simply as Ras), and an immortalizing function, such as Myc (29), adenovirus E1a (53), simian virus 40 (SV40) large T antigen (LT) (38), or human papillomavirus E…”
BackgroundNkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis
Anderson, P. D., McKissic, S. A., Logan, M., Roh, M., Franco, O. E., Wang, J., Doubinskaia, I., van der Meer, R., Hayward, S. W., Eischen, C. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58540 · Cited by 77
“Introduction Classic studies showed that malignant transformation is crucially dependent on cooperative interactions between distinct oncogenic mutations (1, 2).”
In Vitro and In Vivo Oncogenic Potential of Bovine Leukemia Virus G4 Protein
Kerkhofs, P., Heremans, H., Burny, A., Kettmann, R., & Willems, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2554-2559.1998 · Cited by 68
“basis of their ability to cooperate to fully transform primary rat embryo fibroblasts (13).”
BackgroundInfluentialRas induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites
Kivinen, L., Tsubari, M., Haapajärvi, T., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203000 · Cited by 76
“The latter e ect is enhanced by a loss of p27Kip1 in a posttranscriptional manner, while expression of either Myc and Ras alone has no e ect on p27 (Leone et al., 1997). p21 is a wide-spectrum inhibitor of G1 and S phase cyclin-Cdk complexes (Xiong et al., 1993) but, on the other hand, functions as an assembly factor…”
BackgroundInfluentialCiardiello, F., Gottardis, M. M., Basolo, F., Pepe, S., Normanno, N., Dickson, R. B., Bianco, A. R., & Salomon, D. S. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060108 · Cited by 68
Lanford, R. E., Wong, C. C., & Butel, J. S. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.5.1043 · Cited by 68
Widespread genetic epistasis among cancer genes
Wang, X., Fu, A. Q., McNerney, M. E., & White, K. P. (2014) · Nature Communications · doi:10.1038/ncomms5828 · Cited by 77
Induction of senescence by oncogenic ras
Palmero, I., & Serrano, M. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)33060-4 · Cited by 76
Dussault, I., & Giguère, V. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1860 · Cited by 67
“After one passage, secondary REFs were transfected by the calcium phosphate method with 2 mg of Ha-ras, 2 mg of RSVN-myc wild type or mutant as indicated, 5 mg of appropriate receptor, and pBluescript II KS as a carrier for a total of 20 mg per 100-mm-diameter tissue culture dish.”
BackgroundInfluentialBrough, D. E., Hofmann, T. J., Ellwood, K. B., Townley, R. A., & Cole, M. D. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1536 · Cited by 63
“For transformation assays (26), subconfluent REF (2 3 10(5) to 7 3 10(5) cells per plate) were fed with fresh culture medium 2 to 4 h before transfection.”
MethodTavassoli, M., Quirke, P., Farzaneh, F., Lock, N., Mayne, L., & Kirkham, N. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.303 · Cited by 67
Jenuwein, T., Müller, D., Curran, T., & Müller, R. (1985) · Cell · doi:10.1016/s0092-8674(85)80035-0 · Cited by 67
Ras activation of genes: Mob-1 as a model.
Liang, P., Averboukh, L., Zhu, W., & Pardee, A. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12515 · Cited by 68
Normal and activated ras oncogenes and their encoded products
Levinson, A. D. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90184-8 · Cited by 67
Jang, J. W.-U., Boxer, R. B., & Chodosh, L. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00404-06 · Cited by 67
“Moreover, while v-Ha-ras has been shown to synergize with MYC in carcinogenesis in several model systems, including the mammary gland (19, 32), to date synergy between c-MYC and Kras2—or between Wnt1 and any ras isoform—has not been demonstrated in vivo.”
BackgroundBlagosklonny, M. V. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.6.1818 · Cited by 76
Rosenwald, I. B. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04171-7 · Cited by 76
Fujii, M., Lyakh, L. A., Bracken, C. P., Fukuoka, J., Hayakawa, M., Tsukiyama, T., Soll, S. J., Harris, M. D., Rocha, S., Roche, K. C., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.006 · Cited by 72
Control of myogenic differentiation by cellular oncogenes
Schneider, M. D., & Olson, E. N. (1988) · Molecular Neurobiology · doi:10.1007/bf02935631 · Cited by 71
Oncogenes and anti‐oncogenes; the molecular basis of tumour behaviour
Wynford‐Thomas, D. (1991) · The Journal of Pathology · doi:10.1002/path.1711650302 · Cited by 66
A new translocation, t(1;3) (p36;q21), in myelodysplastic disorders
Moir, D. J., Jones, P., Pearson, J., Duncan, J., Cook, P., & Buckle, V. (1984) · Blood · doi:10.1182/blood.v64.2.553.553 · Cited by 66
Reviews on Chromosome Studies in Urological Tumors I. Renal Tumors
Meloni, A. M., Bridge, J. A., & Sandberg, A. A. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36565-5 · Cited by 66
Tevethia, M. J., Pipas, J. M., Kierstead, T. D., & Cole, C. N. (1988) · Virology · doi:10.1016/0042-6822(88)90396-0 · Cited by 66
Phillips, J. W., Pan, Y., Tsai, B. L., Xie, Z., Demirdjian, L., Xiao, W., Yang, H. T., Zhang, Y., Lin, C. H., Cheng, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915975117 · Cited by 76
“HRAS is a well-known oncogene that cooperates with Myc to induce carcinogenesis in multiple tissues (56, 57).”
BackgroundHER2 overexpression and cancer targeting
Wang, S., & Hung, M.-C. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90289-1 · Cited by 79
Viruses – seeking and destroying the tumor program
O’Shea, C. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209047 · Cited by 73
“Historically, some of our first insights into the links, or cooperation, between oncogene and tumor-suppressor pathways came from rodent cell transformation assays with combinations of cellular and DNA viral oncogenes (Rassoulzadegan et al., 1982; Land et al., 1983; Ruley, 1983).”
BackgroundNeuregulin Expression in PNS Neurons: Isoforms and Regulation by Target Interactions
Bermingham‐McDonogh, O., Xu, Y.-T., Marchionni, M. A., & Scherer, S. S. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0654 · Cited by 65
Functional genetics and experimental models of human cancer
Zhao, J. J., Roberts, T. M., & Hahn, W. C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.05.005 · Cited by 71
“18 Land, H. et al. (1983) Tumorigenic conversion of primary embryo”
BackgroundRelative resistance to 1,25-dihydroxyvitamin D3 in a keratinocyte model of tumor progression.
Sébag, M., Henderson, J. E., Rhim, J. S., & Kremer, R. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49818-9 · Cited by 65
Immortalization of bipotential and plastic glio-neuronal precursor cells.
Evrard, C., Borde, I., Marin, P., Galiana, E., Prémont, J., Gros, F., & Rouget, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3062 · Cited by 65
Kornbluth, S. A., Cross, F. R., Harbison, M., & Hanafusa, H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1545 · Cited by 65
Sukumar, S. V., Pulciani, S., Doniger, J., DiPaolo, J. A., Evans, C. H., Zbar, B., & Barbacid, M. (1984) · Science · doi:10.1126/science.6322298 · Cited by 65
Young, K. H., Xie, Q., Zhou, G., Eickhoff, J. C., Sanger, W. G., Aoun, P. A., & Chan, W. C. (2007) · American Journal of Clinical Pathology · doi:10.1309/nkk3fex2be5l7ekb · Cited by 64
Axl-Gas6 Interaction Counteracts E1A-Mediated Cell Growth Suppression and Proapoptotic Activity
Lee, W.-P., Liao, Y., Robinson, D. R., Kung, H.-J., Liu, E. T., & Hung, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8075 · Cited by 64
“However, adenovirus type 5 E1A alone cannot transform established cell lines (5, 23, 36).”
BackgroundVasseur, S., Malicet, C., Calvo, E. L., Labrie, C., Berthézène, P., Dagorn, J. C., & Iovanna, J. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-19 · Cited by 64
Response of heat shock element within the human HSP70 promoter to mutated p53 genes.
Tsutsumi‐Ishii, Y., Tadokoro, K., Hanaoka, F., & Tsuchida, N. (1995) · PubMed · Cited by 74
The Leucine Zipper of c-Myc Is Required for Full Inhibition of Erythroleukemia Differentiation
Smith, M. J., Charron‐Prochownik, D., & Prochownik, E. V. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5333 · Cited by 68
Dominant Oncogenes and Tumor Suppressor Genes in the Pathogenesis of Lung Cancer
Viallet, J., & Minna, J. D. (1990) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/2.3.225 · Cited by 64
Weyman, C. M., Taparowsky, E. J., Wolfson, M., & Ashendel, C. L. (1988) · PubMed · Cited by 64
Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells.
Murphy, S. P., Garbern, J. Y., Odenwald, W. F., Lazzarini, R. A., & Linney, E. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5587 · Cited by 64
Avian v- myc Replaces Chromosomal Translocation in Murine Plasmacytomagenesis
Potter, M., Mushinski, J. F., Mushinski, E. B., Brust, S., Wax, J. S., Wiener, F., Babonits, M., Rapp, U. R., & Morse, H. C. (1987) · Science · doi:10.1126/science.3810165 · Cited by 64
Hauser, S. H., Calorini, L., Wazer, D. E., & Gattoni‐Celli, S. (1993) · PubMed · Cited by 63
Park, S., & Lehner, B. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156102 · Cited by 61
“Subse-quently, the discovery of the phenomenon of oncogene cooperation demonstrated that cancer-causing genomic alterations often cooperate with synergistic effects on cell proliferation or survival (Land et al , 1983; Ruley, 1983).”
Islam, M. K., Jackson, P. J., Rahman, K. M., & Thurston, D. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2015-0017 · Cited by 64
Myc Is an Essential Negative Regulator of Platelet-Derived Growth Factor Beta Receptor Expression
Oster, S. K., Marhin, W. W., Asker, C., Facchini, L. M., Dion, P. A., Funa, K., Post, M., Sedivy, J. M., & Penn, L. Z. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6768-6778.2000 · Cited by 64
“Primary rat embryo fibroblasts (REF) were prepared as described previously (32).”
MethodProliferative activity and tumorigenic conversion: impact on cellular metabolism in 3-D culture
Kunz‐Schughart, L. A., Doetsch, J., Mueller‐Klieser, W., & Groebe, K. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.4.c765 · Cited by 63
“This system is based on Weinberg’s generalized model for tumorigenic conversion of rodent cells, with the first step being immortalization, conferred by the activity of a nuclear oncoprotein, and with the second step being transformation, conferred by the activation of a cytoplasmic oncoprotein (25, 47).”
MethodForoni, C., Galli, R., Cipelletti, B., Caumo, A., Alberti, S., Fiocco, R., & Vescovi, A. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4577 · Cited by 63
“of the viral constructs used to transduce ANSCs, were subjected to the same serial infection (17).”
BackgroundMethodInfluentialNeoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation.
Thraves, P. J., Salehi, Z., Dritschilo, A., & Rhim, J. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1174 · Cited by 63
Corcos, D., Dunda, O., Butor, C., Cesbron, J.-Y., Lorès, P., Bucchini, D., & Jami, J. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00230-2 · Cited by 68
Lachman, H. M., Hatton, K. S., Skoultchi, A. I., & Schildkraut, C. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5323 · Cited by 63
Danielsson, F., Skogs, M., Huss, M., Rexhepaj, E., O’Hurley, G., Klevebring, D., Pontén, F., Gad, A. K. B., Uhlén, M., & Lundberg, E. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216436110 · Cited by 70
“There are several studies where genetic elements such as oncogenes have been introduced to different types of cells in an accumulative order as an attempt to mimic the natural steps of transformation (7, 8).”
BackgroundCancer as robust intrinsic state shaped by evolution: a key issues review
Yuan, R., Zhu, X., Wang, G., Li, S., & Ao, P. (2017) · Reports on Progress in Physics · doi:10.1088/1361-6633/aa538e · Cited by 72
The H-2KbtsA58 transgenic mouse: A new tool for the rapid generation of novel cell lines
Noble, M., Groves, A. K., Ataliotis, P., Ikram, Z., & Jat, P. (1995) · Transgenic Research · doi:10.1007/bf01969114 · Cited by 66
p53 Increases Experimental Metastatic Capacity of Murine Carcinoma Cells
Pohl, J., Goldfinger, N., Radler‐Pohl, A., Rotter, V., & Schirrmacher, V. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.5.2078 · Cited by 62
Georges‐Labouesse, E., Croissant, O., Bonneaud, N., & Orth, G. (1984) · Journal of Virology · doi:10.1128/jvi.51.2.530-538.1984 · Cited by 62
“It has recently, been shown that the cooperation between a gene of an oncogenic DNA virus and an activated cellular oncogene permits the tumorigenic conversion of primary cells in culture (16).”
BackgroundAlemà, S., Tatò, F., & Boettiger, D. E. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.3.538 · Cited by 62
Kennedy, A. L., McBryan, T., Enders, G. H., Johnson, F. B., Zhang, R., & Adams, P. D. (2010) · Cell Division · doi:10.1186/1747-1028-5-16 · Cited by 61
“Regardless of the basis for these differences, it will ultimately be important to determine whether the relative ease of transformation of mouse cells, compared to human cells [28,29], stems, at least in part, from their Figure 4 Senescent MEFs do not downregulate expression of”
BackgroundMaking Better Transgenic Models: Conditional, Temporal, and Spatial Approaches
Ristevski, S. (2005) · Molecular Biotechnology · doi:10.1385/mb:29:2:153 · Cited by 68
Of Mice and Myc: c-Myc and Mammary Tumorigenesis
Jamerson, M. H., Johnson, M. D., & Dickson, R. B. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023586.69263.0b · Cited by 62
“One powerful piece of evidence for the multistep nature of tumorigenesis comes from the in vitro study demonstrating that transformation of rat embryo fibroblasts is absent when ras or myc oncogenes are expressed singly and present when both are simultaneously expressed (36).”
BackgroundClausen, N., Andersson, P., & Tommerup, N. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb11135.x · Cited by 61
Metadata
- Authors
- Land, H., Parada, L. F., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5927
- Pages
- 596-602
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989009382
- Cited by
- 2,804
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 22 · 2023: 15 · 2022: 17 · 2021: 24 · 2020: 22 · 2019: 36 · 2018: 17 · 2017: 23 · 2016: 24 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 37
- FWCI
- 96.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- embryonic fibroblasts, oncogene cooperation, oncogenic Ras, MYC gene, polyomavirus large T antigen, cell immortalization, transfection
- MeSH terms
- Animals, Antigens, Viral, Antigens, Viral, Tumor, Cell Line, Cell Transformation, Viral, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Genes, Viral, Genetic Complementation Test, Oncogenes, Phenotype, Polyomavirus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.